肺结核
医学
回顾性队列研究
抗药性
内科学
耐药结核
广泛耐药结核
队列
单核苷酸多态性
队列研究
耐多药结核病
人口
结核分枝杆菌
儿科
基因型
基因
遗传学
病理
生物
环境卫生
作者
Meng Li,Yong Qiu,Mingcheng Guo,Shu Zhang,Gengsheng Wang,Ya Wang,Lan Xia,Qian Gao
出处
期刊:Tuberculosis
[Elsevier BV]
日期:2022-01-31
卷期号:133: 102174-102174
被引量:11
标识
DOI:10.1016/j.tube.2022.102174
摘要
Recurrent tuberculosis (TB) in China has been studied in urban areas but not in rural settings. We conducted a retrospective cohort study on all successfully treated bacteriologically confirmed TB patients between 2009 and 2020 in Wusheng County, Sichuan Province using whole-genome sequencing (WGS). Isolates differing by ≤ 12 single nucleotide polymorphisms (SNPs) were considered relapse, otherwise were considered exogenous reinfection, and molecular drug susceptibility results were also compared. In total, 4.9% (75/1532) of successfully treated cases had subsequent bouts of TB, with 4 patients having two subsequent bouts, yielding a total of 79 events and a rate of 8.56 (95% CI 6.86-10.67) cases per 1000 person years, 8.9 times higher than in the general population. Most recurrences (74.4%, 58/79) occurred within three years. The risk for recurrent TB was increased for men and patients with drug-resistant isolates. Among the 44 recurrent events with genotyped paired isolates, 39 were classified as relapse and 5 as exogenous reinfection. Ten (25%, 10/40) recurrent patients acquired new resistance during treatment. Recurrent TB in rural Wusheng was mostly relapse and associated with drug resistance, suggesting the need to improve patient management, resistance testing and patient follow-up for at least 3 years after completing treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI